The weekly shot reportedly costs about 130,000 won for the first month, roughly half of Mounjaro's lowest dose supply price.
Recap by typeshit. Full story at Korea Biomedical Review.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
Stanford doctors look at what peptides are and whether the online wellness hype holds up, covering possible upsides alongside the risks.
The author says they searched the phase three results for a catch and found none, and explains why the strong numbers still worry them.
Loading…